Indian Drug Regulators Closely Watch Ads On Oral Contraceptives - Is A Ban In The Offing Or Will The Doctor Decide?
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Controversial television advertisements on the use of emergency contraceptive pills marketed by companies like Cipla and Mankind Pharma is deepening the divide between pharmaceutical companies and Indian drug regulators
You may also be interested in...
Indian Drug Regulator Softens Stand On Emergency Contraceptive Pills; Ad Campaigns On As Doctors Advise Caution
MUMBAI - Less than six months after the Drug Controller General of India clamped a ban over mass media advertisements of popular oral emergency contraceptive I-pill, the segment leader that changed hands from Cipla to Piramal Healthcare is aggressively back on national television channels with frequent time spots
Indian Drug Regulator Softens Stand On Emergency Contraceptive Pills; Ad Campaigns On As Doctors Advise Caution
MUMBAI - Less than six months after the Drug Controller General of India clamped a ban over mass media advertisements of popular oral emergency contraceptive I-pill, the segment leader that changed hands from Cipla to Piramal Healthcare is aggressively back on national television channels with frequent time spots
Indian Drug Firms Realign Marketing Structures For More Profitability And Cost Savings
MUMBAI - Impending risk from loss of market share and fewer products in their pipelines are pushing small and medium-sized Indian drug makers to restructure their marketing operations